Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Treatment of Enteropathy Associated T Cell Lymphoma with Combination Chemotherapy Followed by Autologous Stem Cell Transplantation.

Mark J. Bishton, Andrew P. Haynes, Jenny L. Byrne, Nigel H. Russell

Blood (2006) 108 (11): 5424.

https://doi.org/10.1182/blood.V108.11.5424.5424

Published: 2006

Journal Articles

Ifosphamide, Etoposide and Epirubicin (IVE) Is an Effective Combined Salvage and Peripheral Blood Stem Cell Mobilisation Regimen for Transplant-Eligible Patients with Lymphoma.

Mark J. Bishton, Richard Lush, Nigel H. Russell, Bronwen E. Shaw, Andrew P. Haynes

Blood (2006) 108 (11): 2432.

https://doi.org/10.1182/blood.V108.11.2432.2432

Published: 2006

Journal Articles

Reduced Intensity Allogeneic Transplantation Using BEAM-Alemtuzumab in Patients with Lymphoid Malignancy: Long Term Results and Impact of Intervention with DLI.

Emma P. Das-Gupta, DM, Jennifer L. Byrne, PhD, Charles Craddock, MD, Stephen Robinson, PhD, Stephen Devereux, MD, Antonio Pagliuca, MD, Grant McQuaker, DM, Andrew P. Haynes, DM, Ghulam Mufti, MD, Nigel H. Russell, MD

Blood (2005) 106 (11): 2890.

https://doi.org/10.1182/blood.V106.11.2890.2890

Published: 2005

Journal Articles

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients

Rowena D. Faulkner, Charles Craddock, Jennifer L. Byrne, Prem Mahendra, Andrew P. Haynes, Hugh G. Prentice, Michael Potter, Antonio Pagliuca, Aloysius Ho, Stephen Devereux, Grant McQuaker, Ghulam Mufti, John Liu Yin, Nigel H. Russell

Blood (2004) 103 (2): 428–434.

https://doi.org/10.1182/blood-2003-05-1406

Published: 2004

Journal Articles

Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma

Sharon L. Barrans, Ian Carter, Roger G. Owen, Faith E. Davies, Russell D. Patmore, Andrew P. Haynes, Gareth J. Morgan, Andrew S. Jack

Blood (2002) 99 (4): 1136–1143.

https://doi.org/10.1182/blood.V99.4.1136

Published: 2002

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Treatment of Enteropathy Associated T Cell Lymphoma with Combination Chemotherapy Followed by Autologous Stem Cell Transplantation.

Ifosphamide, Etoposide and Epirubicin (IVE) Is an Effective Combined Salvage and Peripheral Blood Stem Cell Mobilisation Regimen for Transplant-Eligible Patients with Lymphoma.

Reduced Intensity Allogeneic Transplantation Using BEAM-Alemtuzumab in Patients with Lymphoid Malignancy: Long Term Results and Impact of Intervention with DLI.

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients

Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Treatment of Enteropathy Associated T Cell Lymphoma with Combination Chemotherapy Followed by Autologous Stem Cell Transplantation.

Ifosphamide, Etoposide and Epirubicin (IVE) Is an Effective Combined Salvage and Peripheral Blood Stem Cell Mobilisation Regimen for Transplant-Eligible Patients with Lymphoma.

Reduced Intensity Allogeneic Transplantation Using BEAM-Alemtuzumab in Patients with Lymphoid Malignancy: Long Term Results and Impact of Intervention with DLI.

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients

Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only